Home/Database/AOD-9604
MetabolicClinical Trials

AOD-9604

Anti-Obesity Drug (Modified GH Fragment)

16 Amino Acids · MW: 1,815.08 Da

Amino Acids

16

Molecular Weight

1,815.08 Da

Half-life

~30 minutes

Research Score

4.4

Studies

87

Storage

N/A

What is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone (HGH fragment 177-191) specifically designed for fat metabolism. It stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or tissue growth, making it a targeted fat-loss peptide without typical GH side effects.

Key Benefits & Mechanisms

Stimulates fat breakdown (lipolysis)

Inhibits fat formation (lipogenesis)

No effect on blood sugar or growth

Does not cause insulin resistance

Promotes cartilage repair

No antibody formation reported

Mimics natural GH fat-burning mechanism

Research Summary

AOD-9604 completed Phase II clinical trials for obesity. TGA-approved in Australia as a food supplement. Demonstrated significant fat reduction without GH-related side effects. Also shows promise for osteoarthritis and cartilage repair.